Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Raffles Medical Group Ltd
Raffles Medical Group runs private hospitals and clinics, and sells health insurance, mostly in Singapore and China.
Raffles Medical Group is a private healthcare company that runs hospitals and clinics, and sells health insurance on the side. If you live in Singapore and want to see a doctor without queuing at a public hospital, or your company sends you for a health screening, there is a good chance you end up in one of its clinics or hospitals. It also treats patients from outside Singapore who travel there for care.
The core of the business is straightforward: it owns and operates Raffles Hospital in Singapore, a large private hospital, plus a network of family clinics and specialist centres around the island. It has also spent years building hospitals in China, including in Chongqing and Shanghai, and runs clinics in Vietnam, Cambodia and Japan. Patients pay out of their own pocket or through insurance, and companies pay for employee health checks and medical coverage. The insurance arm, Raffles Health Insurance, matters because it helps feed patients into the group's own hospitals and clinics, and it gives the company a second stream of income beyond treating people. Growth has not been a straight line. The China hospitals were a big bet that took years and a lot of capital to build, and they have been slower to make money than the Singapore core. During the pandemic, the group got a temporary boost from Covid testing and vaccination work, which flattered profits and then faded. That is an important thing to understand about healthcare: demand is steady, but new hospitals are expensive, take years to fill with patients, and only pay off if you can attract enough doctors and enough paying patients. The Singapore business is the cash engine. Raffles Hospital competes with other private providers, and its clinics compete with everyone from small GP practices to big chains. What makes it sticky is its brand, its spread of locations, and the fact that a patient can move from a family clinic to a specialist to a hospital bed without leaving the network. The group also pays a dividend, which is a signal that management sees the Singapore operation as mature enough to return cash while still funding expansion.
The main risk is simple: private healthcare in Singapore is crowded and costs are watched closely by the government and employers. Growing in China means competing with local hospitals and building trust slowly. So the story is a steady, well-known local healthcare brand trying to turn itself into a regional one, while keeping the Singapore machine humming.
Saved answer · last researched 12 Nov 2026